• Andreas Goebel, Nadia DuToit, and Frank Huygen.
• Pain Research Institute, Liverpool University, Clinical Sciences Building, University Hospital Aintree/The Walton Centre, Liverpool L9 7AL, UK. andreasgoebel@rocketmail.com
• Pain Pract. 2011 Jul 1;11(4):344-52.

AbstractWith few exceptions, anesthesiologists have not received training in the use of immune modulating drugs (IMDs); but recent evidence suggests that such drugs may be effective in reducing chronic pain. We therefore wished to learn how anesthesiologists working in pain medicine might envisage the treatment of their patients with IMDs in the future. We expected that anesthesiologists would want to refer patients for treatment with IMDs to medical colleagues, such as oncologists or rheumatologists, with prior experience in using these drugs, rather than treat these patients within their own practice. We conducted questionnaire surveys among anesthesiologists working in pain medicine in both the Netherlands and the U.K. to explore their views on using IMDs. Contrary to what we had expected, we found that a majority of the respondents would administer IMDs within their own practice, after appropriate training. The overall response rates were 30% and 23%, respectively; therefore, no firm conclusions can be drawn as to the views of the majority of practicing pain specialists. Our findings may have implications for the planning of both health service delivery and training in pain medicine.© 2010 The Authors. Pain Practice © 2010 World Institute of Pain.

14 keywords...

hide…